This should be a fairly big deal in disclosing data in clinical trials. From my personal experience I know GILD is a big offender and I likely would have avoided a very serious condition if this rule had been in effect a year or so earlier. A step forward.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.